# Philip Raskin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philip-raskin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,657 |
| Field | Diabetes Management and Research |
| h-index | 79 |
| i10-index | 253 |
| Last Known Institution | The University of Texas Southwestern Medical Center |
| OpenAlex ID | https://openalex.org/A5015275535 |
| Works | 436 |

## Researcher papers

- [Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function](https://scholariq.org/papers/rituximab-b-lymphocyte-depletion-and-preservation-of-beta-cell-function/)
- [Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes](https://scholariq.org/papers/bardoxolone-methyl-and-kidney-function-in-ckd-with-type-2-diabetes/)
- [Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)](https://scholariq.org/papers/efficacy-and-safety-of-the-human-glucagon-like-peptide-1-analog-liraglutide-in/)
- [Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension](https://scholariq.org/papers/metabolic-effects-of-carvedilol-vs-metoprolol-in-patients-with-type-2-diabetes/)
- [Vitamin D Supplementation and Prevention of Type 2 Diabetes](https://scholariq.org/papers/vitamin-d-supplementation-and-prevention-of-type-2-diabetes/)
- [Cardiac Steatosis in Diabetes Mellitus](https://scholariq.org/papers/cardiac-steatosis-in-diabetes-mellitus/)
- [Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/co-stimulation-modulation-with-abatacept-in-patients-with-recent-onset-type-1/)
- [Initiating Insulin Therapy in Type 2 Diabetes](https://scholariq.org/papers/initiating-insulin-therapy-in-type-2-diabetes/)
- [Hyperglycemia and Acute Coronary Syndrome](https://scholariq.org/papers/hyperglycemia-and-acute-coronary-syndrome/)
- [Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy](https://scholariq.org/papers/randomized-trial-of-an-inhibitor-of-formation-of-advanced-glycation-end-products/)
- [Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy](https://scholariq.org/papers/addition-of-angiotensin-receptor-blockade-or-mineralocorticoid-antagonism-to/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [The University of Texas Southwestern Medical Center](https://scholariq.org/institutions/the-university-of-texas-southwestern-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.